Valuation Getinge AB Deutsche Boerse AG
Stocks
GTN
SE0000202624
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.58 EUR | -1.62% |
|
+1.53% | -6.94% |
| 07-14 | Getinge is expected to report adjusted EBITA of SEK 1,373m, Modular | FW |
| 07-09 | Adrigo Small & Midcap L/S fell 5.0 percent in June, Hansa Biopharma and Braincool contributed the most positively | FW |
Company Valuation: Getinge AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 107,613 | 58,914 | 61,092 | 49,449 | 59,594 | 56,272 | - | - |
| Change | - | -45.25% | 3.7% | -19.06% | 20.52% | -5.58% | - | - |
| Enterprise Value (EV) 1 | 111,222 | 61,516 | 69,104 | 59,916 | 69,434 | 64,871 | 62,889 | 60,822 |
| Change | - | -44.69% | 12.34% | -13.3% | 15.89% | -6.57% | -3.06% | -3.29% |
| P/E | 36.2x | 23.6x | 25.3x | 30.2x | 26.4x | 19.7x | 16.9x | 15.1x |
| PBR | 4.27x | 1.93x | 2.01x | 1.49x | 2.02x | 1.8x | 1.7x | 1.59x |
| PEG | - | -1.5x | -7.98x | -0.9x | 0.7x | 0.7x | 1x | 1.3x |
| Capitalization / Revenue | 3.98x | 2.08x | 1.92x | 1.42x | 1.7x | 1.61x | 1.53x | 1.46x |
| EV / Revenue | 4.11x | 2.17x | 2.17x | 1.72x | 1.99x | 1.85x | 1.71x | 1.57x |
| EV / EBITDA | 16.5x | 10.4x | 12.4x | 9.02x | 10.6x | 9.72x | 8.61x | 7.71x |
| EV / EBIT | 22.5x | 15x | 18.9x | 13.2x | 15.5x | 13.7x | 11.9x | 10.5x |
| EV / FCF | 19.8x | 32.4x | 43.1x | 18.3x | 26.4x | 18.5x | 17.8x | 14.3x |
| FCF Yield | 5.06% | 3.08% | 2.32% | 5.45% | 3.79% | 5.39% | 5.61% | 6.99% |
| Dividend per Share 2 | 4 | 4.25 | 4.4 | 4.6 | 4.75 | 5.053 | 5.544 | 5.896 |
| Rate of return | 1.01% | 1.96% | 1.96% | 2.53% | 2.17% | 2.45% | 2.68% | 2.85% |
| EPS 2 | 10.9 | 9.15 | 8.86 | 6.01 | 8.29 | 10.51 | 12.21 | 13.65 |
| Distribution rate | 36.7% | 46.4% | 49.7% | 76.5% | 57.3% | 48.1% | 45.4% | 43.2% |
| Net sales 1 | 27,049 | 28,292 | 31,827 | 34,759 | 34,969 | 35,006 | 36,811 | 38,628 |
| EBITDA 1 | 6,754 | 5,891 | 5,574 | 6,646 | 6,581 | 6,675 | 7,302 | 7,893 |
| EBIT 1 | 4,939 | 4,096 | 3,653 | 4,549 | 4,494 | 4,752 | 5,280 | 5,794 |
| Net income 1 | 2,970 | 2,491 | 2,412 | 1,638 | 2,258 | 2,851 | 3,297 | 3,700 |
| Net Debt 1 | 3,609 | 2,602 | 8,012 | 10,467 | 9,840 | 8,600 | 6,617 | 4,550 |
| Reference price 2 | 395.10 | 216.30 | 224.30 | 181.55 | 218.80 | 206.60 | 206.60 | 206.60 |
| Nbr of stocks (in thousands) | 272,370 | 272,370 | 272,370 | 272,370 | 272,370 | 272,370 | - | - |
| Announcement Date | 1/28/22 | 2/1/23 | 2/1/24 | 1/28/25 | 1/27/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 63.11x | 7.54x | 40.24x | -.--% | 12.44B | |
| 30.92x | 6.4x | 17.37x | 1.22% | 5.96B | |
| 22.7x | 1.13x | 7.02x | -.--% | 4.22B | |
| 28.18x | 8.38x | 21.33x | 0.71% | 4.25B | |
| 17.27x | 3.03x | 14.49x | 3.78% | 3.96B | |
| -18.25x | 454.05x | -78.84x | -.--% | 1.89B | |
| -9.8x | 2.25x | -9.92x | - | 1.8B | |
| 19.92x | 2.37x | 9.57x | 2.18% | 1.54B | |
| 27.41x | - | - | - | 1.29B | |
| Average | 20.16x | 60.64x | 2.66x | 1.13% | 4.15B | |
| Weighted average by Cap. | 33.93x | 29.06x | 17.47x | 0.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- GETI B Stock
- GTN Stock
- Valuation Getinge AB
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
